[D-Ala2]-GIP (human)

This compound is a highly potent and enzymatically stable GIP receptor agonist (EC50 ~630 pM) . It enhances glucose tolerance and insulin secretion in metabolic disease models and demonstrates neuroprotective effects in models of Parkinson's disease, supporting research in diabetes, obesity, and neurodegeneration.